Lincoln National Corp’s Zimmer Biomet ZBH Stock Holding History

Lincoln National Corp’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,591	Closed	-$210K	–	1168
2024 Q1	$210K	Buy	+1,591	New	+$199K	﹤0.01%	1127
2023 Q3	–	Sell	-1,558	Closed	-$227K	–	1069
2023 Q2	$227K	Sell	1,558 -21	-1%	-$2.85K	﹤0.01%	912
2023 Q1	$204K	Buy	+1,579	New	+$198K	﹤0.01%	927
2022 Q4	–	Sell	-2,043	Closed	-$213K	–	987
2022 Q3	$213K	Buy	2,043 +88	+5%	+$9.66K	0.01%	796
2022 Q2	$206K	Sell	1,955 -1,179	-38%	-$140K	﹤0.01%	800
2022 Q1	$401K	Buy	3,134 +872	+39%	+$105K	0.01%	617
2021 Q4	$279K	Buy	2,262 +202	+10%	+$26.4K	0.01%	734
2021 Q3	$293K	Buy	2,060 +343	+20%	+$50.5K	0.01%	693
2021 Q2	$268K	Buy	1,717 +190	+12%	+$30.8K	0.01%	714
2021 Q1	$237K	Buy	1,527 +83	+6%	+$12.9K	0.01%	702
2020 Q4	$216K	Buy	+1,444	New	+$204K	0.01%	682
2020 Q1	–	Sell	-1,502	Closed	-$218K	–	683
2019 Q4	$218K	Buy	+1,502	New	+$207K	0.01%	583
2018 Q1	–	Sell	-1,887	Closed	-$221K	–	630
2017 Q4	$221K	Buy	+1,887	New	+$213K	0.01%	577

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lincoln National Corp's ZBH Position: Q2 2024 in Review

Lincoln National Corp sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 1,591 shares — an estimated $210K sold.

Lincoln National Corp first reported a position in ZBH in Q4 2017 and held it in 13 quarters. The position peaked at $401K in Q1 2022. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

Lincoln National Corp reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
Lincoln National Corp sold 1,591 Zimmer Biomet shares in Q2 2024, an estimated $210K.
Lincoln National Corp first reported a position in Zimmer Biomet in Q4 2017 and held it in 13 quarters.
Lincoln National Corp's Zimmer Biomet position peaked at $401K in Q1 2022.
1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.